Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Pharmaceuticals ETF

+ Add to Watchlist

XPH:US

111.3800 USD 2.7600 2.42%

As of 20:04:05 ET on 01/30/2015.

Snapshot for SPDR S&P Pharmaceuticals ETF (XPH)

Open: 114.2500 High - Low: 114.2500 - 111.2100 Primary Exchange: NYSE Arca
Volume: 119,190 52-Week Range: 81.4015 - 115.1100 Beta vs SPSIPHTR: 1.0028

ETF Chart for XPH

No chart data available.
  • XPH:US 111.3800
  • 1D
  • 1M
  • 1Y
114.1400
Interactive XPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XPH

SPDR Pharmaceuticals ETF is an exchange-traded fund incorporated in the USA. The Fund's objective is to replicate as closely as possible the performance of the S&P Pharmaceuticals Select Industry Index, an equal-weighted index.

Inception Date: 2006-06-22 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER / MICHAEL FEEHILY
Web Site: www.spdrs.com

Fundamentals for XPH

NAV (on 2015-01-30) 111.3235
Assets (M) (on 2015-01-30) 1,107.6836
Shares out (M) 9.95
Market Cap (M) 1,108.25
% Premium 0.05
Average 52-Week % Premium 0.0169
Fund Leveraged N

Dividends for XPH

Dividend Type Long Term Cap Gain
Dividend Frequency Quarter
Last Dividend Net (on 2014-12-19) 2.4324
Dividend Yield (ttm) 5.38%

Performance for XPH

1-Month +4.73% 1-Year +33.73%
3-Month +10.04% 3-Year +33.37%
Year To Date +3.17% 5-Year +27.38%
Expense Ratio 0.35

Top Fund Holdings for XPH

Filing Date: 01/29/2015
Name Position Value % of Total
Horizon Pharma Plc 2,532,711 43,258,704 3.814%
Salix Pharmaceuticals Ltd 311,409 42,083,812 3.710%
Depomed Inc 2,124,858 40,074,822 3.533%
Impax Laboratories Inc 1,033,061 38,936,069 3.433%
Pacira Pharmaceuticals Inc/DE 353,366 38,679,442 3.410%
Endo International PLC 468,041 38,210,867 3.369%
Lannett Co Inc 738,704 37,016,457 3.264%
Mallinckrodt PLC 339,879 36,958,442 3.259%
Medicines Co/The 1,267,846 36,260,396 3.197%
Auxilium Pharmaceuticals Inc 972,293 35,459,526 3.126%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil